Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Jon C. Ogg | Jun 28, 2019 at 12:15 PM EDT

Why Avid Bioservices Stock Could Still Double, Maybe

Avid Bioservices beat expectations around earnings, and it is adding customers and growing its backlog. One analyst has just reversed…

Chris Lange | Jun 27, 2019 at 12:20 PM EDT

Adaptive Biotechnologies Enters the Market With a Bang

Adaptive Biotechnologies entered the market with a bang on Thursday, well above the high end of the expected price range.

Paul Ausick | Jun 27, 2019 at 10:55 AM EDT

Why Centerbridge Would Buy Magellan Health — and Keep It

Private equity firm Centerbridge Partners is reportedly discussing an acquisition of health care provider Magellan Health. While not on the…

Chris Lange | Jun 27, 2019 at 10:20 AM EDT

Thursday’s Top 4 Biotech Movers

Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a…

Chris Lange | Jun 27, 2019 at 8:50 AM EDT

Why Investors Are Pulling Out Their Hair Over Aclaris Alopecia Study

Aclaris Therapeutics shares sharply dropped early on Thursday after the firm announced results from its midstage trial in alopecia areata.

Chris Lange | Jun 26, 2019 at 10:05 AM EDT

Big Biotechs Scare Off Short Sellers

The June 14 short interest data has been compared with the previous report, and short interest in most of these…

Douglas A. McIntyre | Jun 26, 2019 at 9:27 AM EDT

Study: Life expectancy varies by neighborhood — and the gap is huge

A recent report shows that in some American cities, the lifespan can be nearly 30 years longer in one neighborhood…

Chris Lange | Jun 26, 2019 at 8:30 AM EDT

Short Sellers Seek Direction on Big Pharma

The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jun 25, 2019 at 11:45 AM EDT

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Allergan shares jumped on Tuesday after the company announced that it would be acquired by AbbVie in a cash and…

Chris Lange | Jun 25, 2019 at 9:55 AM EDT

Why Akorn Is in Trouble With the FDA Again

Akorn shares dipped on Tuesday after the firm announced that it received a warning letter from the FDA related to…

Chris Lange | Jun 24, 2019 at 2:10 PM EDT

Big Biotechs Scare Off Short Sellers

The June 14 short interest data has been compared with the previous report, and short interest in most of these…

Hristina Byrnes | Jun 24, 2019 at 10:30 AM EDT

Many Pregnant Women Get Too Much Folic Acid, New Study Finds

One piece of nutritional advice unfailingly drummed into the heads of women who are pregnant or trying to become pregnant…

Chris Lange | Jun 24, 2019 at 9:35 AM EDT

How Minerva Neursciences Is Outsmarting Insomia

Minerva Neurosciences saw its shares jump on Monday after the firm announced results from a trial related to an insomnia…

Douglas A. McIntyre | Jun 23, 2019 at 7:25 AM EDT

Is Vacation Good For Your Heart? Yes

Vacation is supposed to be the sort of downtime which is good to clear the mind and relieve tension. It…

Hristina Byrnes | Jun 21, 2019 at 10:39 AM EDT

New Study Links Irregular Heartbeat and Dementia

A new large-scale study conducted by Korean researchers, the results of which were just published in the European Heart Journal,…

1 … 94 95 96 97 98 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why Avid Bioservices Stock Could Still Double, Maybe

Adaptive Biotechnologies Enters the Market With a Bang

Why Centerbridge Would Buy Magellan Health — and Keep It

Thursday’s Top 4 Biotech Movers

Why Investors Are Pulling Out Their Hair Over Aclaris Alopecia Study

Big Biotechs Scare Off Short Sellers

Study: Life expectancy varies by neighborhood — and the gap is huge

Short Sellers Seek Direction on Big Pharma

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Why Akorn Is in Trouble With the FDA Again

Big Biotechs Scare Off Short Sellers

Many Pregnant Women Get Too Much Folic Acid, New Study Finds

How Minerva Neursciences Is Outsmarting Insomia

Is Vacation Good For Your Heart? Yes

New Study Links Irregular Heartbeat and Dementia

Small Caps Are Beating the S&P for Once. This Fund Pays 14% While They Run

MARA Holdings Falls 7%, Cipher Mining Drops 6%, TeraWulf Slides 4% as Q2 Losses Outweigh Bitcoin’s $65K Push

Palantir Surges 10%, UiPath Rises 7%, C3.ai Gains 5% as Agentic AI Stocks Rally Together

At 63, He Entered Maine’s Free Shipyard Training While Collecting Unemployment and Social Security. Then the Paycheck Changed the Math.

The $1 Million 401(k) Strategy That Doubles Your Annual Payout Before Age 59.5

Small Caps Are Beating the S&P for Once. This Fund Pays 14% While They Run

MARA Holdings Falls 7%, Cipher Mining Drops 6%, TeraWulf Slides 4% as Q2 Losses Outweigh Bitcoin’s $65K Push

Health and Healthcare Articles

All Health and Healthcare Articles

Why Avid Bioservices Stock Could Still Double, Maybe

Adaptive Biotechnologies Enters the Market With a Bang

Why Centerbridge Would Buy Magellan Health — and Keep It

Thursday’s Top 4 Biotech Movers

Why Investors Are Pulling Out Their Hair Over Aclaris Alopecia Study

Big Biotechs Scare Off Short Sellers

Study: Life expectancy varies by neighborhood — and the gap is huge

Short Sellers Seek Direction on Big Pharma

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Why Akorn Is in Trouble With the FDA Again

Big Biotechs Scare Off Short Sellers

Many Pregnant Women Get Too Much Folic Acid, New Study Finds

How Minerva Neursciences Is Outsmarting Insomia

Is Vacation Good For Your Heart? Yes

New Study Links Irregular Heartbeat and Dementia

Small Caps Are Beating the S&P for Once. This Fund Pays 14% While They Run

MARA Holdings Falls 7%, Cipher Mining Drops 6%, TeraWulf Slides 4% as Q2 Losses Outweigh Bitcoin’s $65K Push

Palantir Surges 10%, UiPath Rises 7%, C3.ai Gains 5% as Agentic AI Stocks Rally Together

Featured Reads

At 63, He Entered Maine’s Free Shipyard Training While Collecting Unemployment and Social Security. Then the Paycheck Changed the Math.

The $1 Million 401(k) Strategy That Doubles Your Annual Payout Before Age 59.5